project id: TCGA-ESCA; case submitter id: TCGA-L7-A56G; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 7.5; age at index: 65; days to birth: -24106; days to death: 330; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1947; age at diagnosis: 24106; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 245.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 149; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-L7-A56G-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 45.0; percent tumor cells: 50.0; percent tumor nuclei: 100.0;